TA
CADX

Teachers Advisors’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Teachers Advisors’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-98,986
Closed -$896K – 3113
2013
Q4 		$896K Buy
98,986
+8,390
+9% +$60.6K ﹤0.01% 2062
2013
Q3 		$572K Buy
90,596
+4,340
+5% +$27.6K ﹤0.01% 2238
2013
Q2 		$588K Buy
+86,256
New +$601K ﹤0.01% 2156

Other funds holding CADX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Teachers Advisors's CADX Position: Q1 2014 in Review

Teachers Advisors sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q1 2014, closing a stake of 98,986 shares — an estimated $896K sold.

Teachers Advisors first reported a position in CADX in Q2 2013 and held it in 3 quarters. The position peaked at $896K in Q4 2013. 3 funds tracked by Wall St. Rank hold CADX as of Q1 2014.

  • Teachers Advisors reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q1 2014 after selling out during the quarter.
  • Teachers Advisors sold 98,986 CADENCE PHARMACEUTICALS, INC COM STK shares in Q1 2014, an estimated $896K.
  • Teachers Advisors first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q2 2013 and held it in 3 quarters.
  • Teachers Advisors's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $896K in Q4 2013.
  • 3 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q1 2014.

Based on Teachers Advisors's 13F filing for Q1 2014, filed 13 May 2014.